137 related articles for article (PubMed ID: 30847724)
1. Smad Anchor for Receptor Activation and Phospho-Smad3 Were Upregulated in Patients with Temporal Lobe Epilepsy.
Zhang W; Du Y; Zou Y; Luo J; Lü Y; Yu W
J Mol Neurosci; 2019 May; 68(1):91-98. PubMed ID: 30847724
[TBL] [Abstract][Full Text] [Related]
2. Smad anchor for receptor activation contributes to seizures in temporal lobe epilepsy.
Yu W; Du Y; Zou Y; Wang X; Stephani U; Lü Y
Synapse; 2017 Mar; 71(3):. PubMed ID: 28035691
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H
Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350
[TBL] [Abstract][Full Text] [Related]
4. Smad anchor for receptor activation (SARA) in TGF-beta signaling.
Tang WB; Ling GH; Sun L; Liu FY
Front Biosci (Elite Ed); 2010 Jun; 2(3):857-60. PubMed ID: 20515759
[TBL] [Abstract][Full Text] [Related]
5. Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.
Runyan CE; Hayashida T; Hubchak S; Curley JF; Schnaper HW
J Biol Chem; 2009 Sep; 284(37):25181-9. PubMed ID: 19620243
[TBL] [Abstract][Full Text] [Related]
6. Smad Anchor for Receptor Activation Regulates High Glucose-Induced EMT via Modulation of Smad2 and Smad3 Activities in Renal Tubular Epithelial Cells.
Tang WB; Ling GH; Sun L; Zhang K; Zhu X; Zhou X; Liu FY
Nephron; 2015; 130(3):213-20. PubMed ID: 26159183
[TBL] [Abstract][Full Text] [Related]
7. ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN.
Sflomos G; Kostaras E; Panopoulou E; Pappas N; Kyrkou A; Politou AS; Fotsis T; Murphy C
J Cell Sci; 2011 Oct; 124(Pt 19):3209-22. PubMed ID: 21878490
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
Zhao BM; Hoffmann FM
Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and functional characterization of recombinant PTD-SARA.
Huang C; Du R; Zhang P; Meng H; Jia H; Song Y; Li M; Zhang Y; Sun S
Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):110-7. PubMed ID: 21266541
[TBL] [Abstract][Full Text] [Related]
10. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
11. SARA is dispensable for functional TGF-β signaling.
Bakkebø M; Huse K; Hilden VI; Forfang L; Myklebust JH; Smeland EB; Oksvold MP
FEBS Lett; 2012 Sep; 586(19):3367-72. PubMed ID: 22819827
[TBL] [Abstract][Full Text] [Related]
12. Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control.
Qin BY; Lam SS; Correia JJ; Lin K
Genes Dev; 2002 Aug; 16(15):1950-63. PubMed ID: 12154125
[TBL] [Abstract][Full Text] [Related]
13. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
Itoh F; Divecha N; Brocks L; Oomen L; Janssen H; Calafat J; Itoh S; Dijke Pt Pt
Genes Cells; 2002 Mar; 7(3):321-31. PubMed ID: 11918675
[TBL] [Abstract][Full Text] [Related]
14. Analysis of transforming growth factor β signaling in chronic rhinosinusitis.
Li YC; An YS; Wang T; Zang HR
Chin Med J (Engl); 2013; 126(17):3340-3. PubMed ID: 24033961
[TBL] [Abstract][Full Text] [Related]
15. Activation of LILRB2 signal pathway in temporal lobe epilepsy patients and in a pilocarpine induced epilepsy model.
Yue J; Li W; Liang C; Chen B; Chen X; Wang L; Zang Z; Yu S; Liu S; Li S; Yang H
Exp Neurol; 2016 Nov; 285(Pt A):51-60. PubMed ID: 27637803
[TBL] [Abstract][Full Text] [Related]
16. Up-regulated ephrinB3/EphB3 expression in intractable temporal lobe epilepsy patients and pilocarpine induced experimental epilepsy rat model.
Huang H; Li R; Yuan J; Zhou X; Liu X; Ou S; Xu T; Chen Y
Brain Res; 2016 May; 1639():1-12. PubMed ID: 26930615
[TBL] [Abstract][Full Text] [Related]
17. The FYVE domain of Smad Anchor for Receptor Activation (SARA) is required to prevent skin carcinogenesis, but not in mouse development.
Chang HM; Lin YY; Tsai PC; Liang CT; Yan YT
PLoS One; 2014; 9(8):e105299. PubMed ID: 25170969
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern of sorting Nexin 25 in temporal lobe epilepsy: a study on patients and pilocarpine-induced rats.
Du Y; Zou Y; Yu W; Shi R; Zhang M; Yang W; Duan J; Deng Y; Wang X; Lü Y
Brain Res; 2013 May; 1509():79-85. PubMed ID: 23518199
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression and spatiotemporal change of Slit2 in neurons and astrocytes in temporal lobe epileptic foci: A study of epileptic patients and experimental animals.
Fang M; Liu GW; Pan YM; Shen L; Li CS; Xi ZQ; Xiao F; Wang L; Chen D; Wang XF
Brain Res; 2010 Apr; 1324():14-23. PubMed ID: 20153733
[TBL] [Abstract][Full Text] [Related]
20. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
